Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can mindfulness calm pregnancy anxiety?

NCT ID NCT07757243

Symptom relief Sponsor: Shenzhen Kangning Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 11, 2026 · Last updated Sep 11, 2026 · Updated 6 times

Summary

This trial tests whether an 8-week group mindfulness program can reduce anxiety, depressive symptoms, and fear of childbirth in pregnant women. Participants at 20-30 weeks of pregnancy are randomly assigned to mindfulness sessions, group discussions, or standard health education. The study also explores how mindfulness may affect attention to pain cues in a subset of participants.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Group mindfulness intervention (behavioral)
What this could lead to
If effective, this could offer a drug-free way to reduce anxiety and fear of childbirth in pregnant women, potentially improving maternal mental health.
What could go wrong
The trial is early and relies on self-reported outcomes; benefits may be modest or not generalize beyond the study setting. Mindfulness is generally safe but may not suit everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

356 people

The number who actually took part.

Started

Sep 2021

Finished

Oct 2022

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Pregnant women at 20 to 30 gestational weeks. * No obvious pregnancy complications. * Able to complete questionnaires independently. * Willing to participate in the study and able to complete the 8-week intervention. * Provided written informed consent. Exclusion Criteria: * Self-harm behavior or suicidal tendency. * Current psychiatric medication use. * Severe mental disorder, such as schizophrenia, bipolar disorder, or organic mental disorder. * Severe somatic disease, such as abnormal liver or renal function, brain injury, heart disease, or epilepsy. * Pregnancy complications or expected inability to complete the intervention or follow-up.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Perinatal anxiety are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Depression

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Perinatal anxiety

Contacts and locations

Locations

  • Shenzhen Kangning Hospital

    Shenzhen, Guangdong, 518020, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.